Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Blevins

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Postgraduate Medicine|June 18, 2011
Control of postprandial glucose levels with insulin in type 2 diabetesThomas Blevins
Diabetes Technology & Therapeutics|September 28, 2012
Hemoglobin A1c values and CGMThomas Blevins
Postgraduate Medicine|June 11, 2013
Value and utility of self-monitoring of blood glucose in non-insulin-treated patients with type 2 diabetes mellitusThomas Blevins
Postgraduate Medicine|January 29, 2010
Therapeutic options that provide glycemic control and weight loss for patients with type 2 diabetesThomas Blevins
Expert Opinion on Drug Safety|March 20, 2015
Combination therapy for patients with uncontrolled type 2 diabetes mellitus: adding empagliflozin to pioglitazone or pioglitazone plus metforminThomas Blevins
Texas Medicine|September 3, 2020
Telemedicine During the COVID-19 Crisis and BeyondThomas Blevins, Kerem Ozer
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 6, 2016
Onset of Glycemic and Weight Outcomes in Patients Initiating Exenatide Once Weekly: The Relationship of Exenatide Exposure with Efficacy over the First 24 Weeks of TreatmentThomas Blevins, James Ruggles, Elise Hardy
Diabetes Care|July 4, 2020
Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2DThomas Blevins, Qianyi Zhang, Juan P Frias, et al.
Diabetes/Metabolism Research and Reviews|April 23, 2016
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial programJohan Jendle, George Grunberger, Thomas Blevins, et al.
Diabetes, Obesity & Metabolism|May 20, 2022
What is the value of faster acting prandial insulin? Focus on ultra rapid lisproTim Heise, Carolina Piras de Oliveira, Rattan Juneja, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Postgraduate Medicine|June 18, 2011
Control of postprandial glucose levels with insulin in type 2 diabetesThomas Blevins
Diabetes Technology & Therapeutics|September 28, 2012
Hemoglobin A1c values and CGMThomas Blevins
Postgraduate Medicine|June 11, 2013
Value and utility of self-monitoring of blood glucose in non-insulin-treated patients with type 2 diabetes mellitusThomas Blevins
Postgraduate Medicine|January 29, 2010
Therapeutic options that provide glycemic control and weight loss for patients with type 2 diabetesThomas Blevins
Expert Opinion on Drug Safety|March 20, 2015
Combination therapy for patients with uncontrolled type 2 diabetes mellitus: adding empagliflozin to pioglitazone or pioglitazone plus metforminThomas Blevins
Texas Medicine|September 3, 2020
Telemedicine During the COVID-19 Crisis and BeyondThomas Blevins, Kerem Ozer
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 6, 2016
Onset of Glycemic and Weight Outcomes in Patients Initiating Exenatide Once Weekly: The Relationship of Exenatide Exposure with Efficacy over the First 24 Weeks of TreatmentThomas Blevins, James Ruggles, Elise Hardy
Diabetes Care|July 4, 2020
Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2DThomas Blevins, Qianyi Zhang, Juan P Frias, et al.
Diabetes/Metabolism Research and Reviews|April 23, 2016
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial programJohan Jendle, George Grunberger, Thomas Blevins, et al.
Diabetes, Obesity & Metabolism|May 20, 2022
What is the value of faster acting prandial insulin? Focus on ultra rapid lisproTim Heise, Carolina Piras de Oliveira, Rattan Juneja, et al.
Pageof 4